Tenofovir Disoproxil Maleate

马来酸替诺福韦二吡呋酯

Report date: 2022/12/07 18:09:10
NME

Base Information

Drug NameTenofovir Disoproxil Maleate
Drug Alias Name马来酸替诺福韦马来酸替诺福韦酯马来酸泰诺福韦酯
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionReverse transcriptase inhibitors
TargetsReverse transcriptase
Therapy Area/IndicationsHepatitis B, ChronicHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsHepatitis B, ChronicHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A